Related references
Note: Only part of the references are listed.Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia
A. Hellmann et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
International prognostic scoring system for Waldenstrom macroglobulinemia
Pierre Morel et al.
BLOOD (2009)
Update on Treatment Recommendations From the Fourth International Workshop on Waldenstrom's Macroglobulinemia
Meletios Athanasios Dimopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Increased Incidence of Transformation and Myelodysplasia/Acute Leukemia in Patients With Waldenstrom Macroglobulinemia Treated With Nucleoside Analogs
Xavier Leleu et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Primary Therapy of Waldenstrom Macroglobulinemia With Bortezomib, Dexamethasone, and Rituximab: WMCTG Clinical Trial 05-180
Steven P. Treon et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura
J. Evan Sadler
BLOOD (2008)
Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia
SP Treon et al.
BLOOD (2006)
Guidelines on the management of Waldenstrom macroglobulinaemia
SA Johnson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia
S Konoplev et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Phase III study of chlorambucil versus fludarabline as initial therapy for Waldenstrom's macroglobulinemia and related disorders
SA Johnson et al.
CLINICAL LYMPHOMA (2005)
CD5, CD10, and CD23 expression in Waldenstrom's macroglobulinemia
ZR Hunter et al.
CLINICAL LYMPHOMA (2005)
Extended rituximab therapy in Waldenstrom's macroglobulinemia
SP Treon et al.
ANNALS OF ONCOLOGY (2005)
Nucleoside transporters in chronic lymphocytic leukaemia
M Pastor-Anglada et al.
LEUKEMIA (2004)
Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy
VL Damaraju et al.
ONCOGENE (2003)
2-chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia
DM Weber et al.
SEMINARS IN ONCOLOGY (2003)
Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenstrom macroglobulinemia in first relapse or with primary refractory disease
V Leblond et al.
BLOOD (2001)
Differential expression of human nucleoside transporters in normal and tumor tissue
M Pennycooke et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Waldenstrom's macroglobulinemia: Clinical features, complications, and management
MA Dimopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
